Why You Should Like Intuitive Surgical, Inc.’s (NASDAQ:ISRG) ROCE

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card!

Today we’ll evaluate Intuitive Surgical, Inc. (NASDAQ:ISRG) to determine whether it could have potential as an investment idea. In particular, we’ll consider its Return On Capital Employed (ROCE), as that can give us insight into how profitably the company is able to employ capital in its business.

Firstly, we’ll go over how we calculate ROCE. Next, we’ll compare it to others in its industry. Finally, we’ll look at how its current liabilities affect its ROCE.

Understanding Return On Capital Employed (ROCE)

ROCE is a measure of a company’s yearly pre-tax profit (its return), relative to the capital employed in the business. All else being equal, a better business will have a higher ROCE. Ultimately, it is a useful but imperfect metric. Author Edwin Whiting says to be careful when comparing the ROCE of different businesses, since ‘No two businesses are exactly alike.’

How Do You Calculate Return On Capital Employed?

The formula for calculating the return on capital employed is:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets – Current Liabilities)

Or for Intuitive Surgical:

0.16 = US$1.2b ÷ (US$8.2b – US$740m) (Based on the trailing twelve months to March 2019.)

Therefore, Intuitive Surgical has an ROCE of 16%.

Check out our latest analysis for Intuitive Surgical

Is Intuitive Surgical’s ROCE Good?

ROCE is commonly used for comparing the performance of similar businesses. Intuitive Surgical’s ROCE appears to be substantially greater than the 10% average in the Medical Equipment industry. We would consider this a positive, as it suggests it is using capital more effectively than other similar companies. Regardless of where Intuitive Surgical sits next to its industry, its ROCE in absolute terms appears satisfactory, and this company could be worth a closer look.

NasdaqGS:ISRG Past Revenue and Net Income, July 1st 2019
NasdaqGS:ISRG Past Revenue and Net Income, July 1st 2019

Remember that this metric is backwards looking – it shows what has happened in the past, and does not accurately predict the future. Companies in cyclical industries can be difficult to understand using ROCE, as returns typically look high during boom times, and low during busts. ROCE is, after all, simply a snap shot of a single year. Future performance is what matters, and you can see analyst predictions in our free report on analyst forecasts for the company.

What Are Current Liabilities, And How Do They Affect Intuitive Surgical’s ROCE?

Current liabilities are short term bills and invoices that need to be paid in 12 months or less. The ROCE equation subtracts current liabilities from capital employed, so a company with a lot of current liabilities appears to have less capital employed, and a higher ROCE than otherwise. To counter this, investors can check if a company has high current liabilities relative to total assets.

Intuitive Surgical has total assets of US$8.2b and current liabilities of US$740m. As a result, its current liabilities are equal to approximately 9.0% of its total assets. Low current liabilities have only a minimal impact on Intuitive Surgical’s ROCE, making its decent returns more credible.

Our Take On Intuitive Surgical’s ROCE

This is good to see, and while better prospects may exist, Intuitive Surgical seems worth researching further. Intuitive Surgical shapes up well under this analysis, but it is far from the only business delivering excellent numbers . You might also want to check this free collection of companies delivering excellent earnings growth.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.